Continuously provide innovative solutions to clinical and health difficulties or pain points

Development strategy

Driven by "innovation" and "clinical value"

Driven by the dual-wheel drive of "innovation" and "clinical value", it is committed to continuously providing innovative solutions for clinical and health pain points and difficulties, focusing on cancer, neurodegenerative diseases, infectious disease POCT, severe POCT and other fields, and firmly believes in "new The innovative development road combining marker/underlying technology/key raw material/automatic instrument"!

Product strategy

Internationally leading, complete categories, covering the whole process of tumor diagnosis

The main product lines include molecular (PCR, NGS), protein (Elisa, chemiluminescence, POCT), exosome (mRNA, miRNA and protein)

Technology strategy

Self-made key raw materials

High affinity recombinant antibodies, humanized or bispecific antibodies, eukaryotic antigens, traceable reference materials, engineered exosome standards, CTC standards, library building reagents, UMI linkers, key reaction enzymes, specific magnetic beads, Modified fillers, etc.

—— There is no "stuck neck" problem of raw materials suitable for industrialization, uncontrollable quality, high cost, long supply cycle and single source.

Talent strategy

Talent is the core asset of Microdiag

Eclectic selection, employment and retention

Talent-oriented, focus on wisdom, inspire innovation, and dare to excel

International strategy

Advance into the United States, realize the dual reporting of core products in China and the United States, and firmly practice "the world is true"

In 5 years, Microdiag entered the first-tier market in the United States and obtained original international recognition and interest premium.




  • 分子产品
  • 免疫产品
  • 仪器设备
  • 新冠产品

  • Suzhou R&D Center

    Continuously provide innovative solutions to clinical and health difficulties or pain points

  • Shanghai R&D Center

    Product development for early detection and detection in the fields of cancer, neurodegenerative diseases, and infectious diseases

  • Anhui R&D Center

    Focus on the creation of immune and molecular POCT production lines

  • US R&D Center

    Professor Zhang Mingdong leads the overseas technical team

  • Detect

  • Cancer prevention and rehabilitation detection technology

    Self-developed ctDNA liquid biopsy and unique tumor marker detection reagents and other tumor prevention and rehabilitation detection technologies are the core

  • Colorectal tumor MRD omics detection

    A "refined" tool for postoperative follow-up management/self-management of bowel cancer patients

  • Tumor genetic testing

    Can carry out common medical laboratory subjects including clinical cytomolecular genetics, clinical immunity, serological testing and other majors, mainly engaged in tumor genetic testing, testing services related to major infectious diseases

  • news


    Stick to the original intention
    The pursuit of excellence team

    Microdiag Biomedical Technology Co., Ltd. was founded in 2008.9.9, located in the national nano high-tech industrialization base - Suzhou Nano City. It is a company focusing on cancer, Alzheimer's, acute infectious diseases and other major diseases. Monitoring is the entry point, focusing on innovative national high-tech enterprises that combine new markers/key technology raw materials/automatic instruments.

  • mission

    To Provide Innovative Solutions for
    the Diagnosis of Critical Diseases

  • View of Value

    Seeking Truth from Facts
    Pioneering on Our Innovation

  • Vision

    To Be a Leading IVD Enterprise Driven by Liquid
    Biopsy Technologies and Targeting International Markets

  • Coporate Culture

    Simplicity Integrity Excellence

  • Hotline: 0512-8187-9848

    Address: Building 16, Northwest District, Suzhou Nano City, No. 99, Jinji Lake Avenue, Suzhou Industrial Park, Jiangsu Province